Technical Analysis for SCPS - Scopus BioPharma Inc.

Grade Last Price % Change Price Change
F 0.0500 -1.96% -0.0010
SCPS closed down 1.96 percent on Wednesday, May 31, 2023, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.96%
Narrow Range Bar Range Contraction -1.96%
Stochastic Reached Oversold Weakness -1.96%
Inside Day Range Contraction -1.96%
Wide Bands Range Expansion -1.96%
Oversold Stochastic Weakness -1.96%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Scopus BioPharma Inc. Description

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancers Gene Therapy Serious Diseases Mri Nitric Oxide

Is SCPS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.1682
52 Week Low 0.04
Average Volume 15,148
200-Day Moving Average 0.0000
50-Day Moving Average 0.0632
20-Day Moving Average 0.0614
10-Day Moving Average 0.0606
Average True Range 0.0179
RSI (14) 45.36
ADX 28.79
+DI 29.9800
-DI 13.9078
Chandelier Exit (Long, 3 ATRs) 0.0513
Chandelier Exit (Short, 3 ATRs) 0.0967
Upper Bollinger Bands 0.0812
Lower Bollinger Band 0.0416
Percent B (%b) 0.21
BandWidth 64.4951
MACD Line -0.0027
MACD Signal Line -0.0013
MACD Histogram -0.0013
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0500
Resistance 3 (R3) 0.0500 0.0500 0.0500
Resistance 2 (R2) 0.0500 0.0500 0.0500 0.0500
Resistance 1 (R1) 0.0500 0.0500 0.0500 0.0500 0.0500
Pivot Point 0.0500 0.0500 0.0500 0.0500 0.0500
Support 1 (S1) 0.0500 0.0500 0.0500 0.0500 0.0500
Support 2 (S2) 0.0500 0.0500 0.0500 0.0500
Support 3 (S3) 0.0500 0.0500 0.0500
Support 4 (S4) 0.0500